2016.07-至今 安徽医科大学，bat36中国官方网站，教辅
2014.09-2015.11 曼彻斯特大学，硕士
2009.09-2014.06 哈尔滨医科大学，学士
1. 杜悠雯,石海涛,韩帅龙,张淑敏,管超奇,王田娟,潘林鑫.MSI2对DHT诱导的KGN细胞增殖凋亡失衡的影响[J].安徽医科大学学报,2023,58(03):464-470.DOI:10.19405/j.cnki.issn1000-1492.2023.03.019.
2. Chan S, Wang X, Wang Z, Du Y, Zuo X, Chen J, Sun R, Zhang Q, Lin L, Yang Y, Yu Z, Zhao H, Zhang H, Chen W. CTSG Suppresses Colorectal Cancer Progression through Negative Regulation of Akt/mTOR/Bcl2 Signaling Pathway. Int J Biol Sci. 2023 Apr 17;19(7):2220-2233.
3. Zhang S, Zhang J, Zhang Q, Liang Y, Du Y, Wang G. Identification of Prognostic Biomarkers for Bladder Cancer Based on DNA Methylation Profile. Front Cell Dev Biol. 2022 Jan 31;9:817086.
4. Qu X, Xie R, Chen L, Feng C, Zhou Y, Li W, Huang H, Jia X, Lv J, He Y, Du Y, Li W, Shi Y, He W. Identifying colon cancer risk modules with better classification performance based on human signaling network. Genomics. 2014 Oct;104(4):242-8.
5. Jia X, Miao Z, Li W, Zhang L, Feng C, He Y, Bi X, Wang L, Du Y, Hou M, Hao D, Xiao Y, Chen L, Li K. Cancer-risk module identification and module-based disease risk evaluation: a case study on lung cancer. PLoS One. 2014 Mar 18;9(3):e92395.
6. Jia X, Li W, Miao Z, Feng C, Liu Z, He Y, Lv J, Du Y, Hou M, He W, Li D, Chen L. Identification of modules related to programmed cell death in CHD based on EHEN. Biomed Res Int. 2014;2014:475379.
1. 安徽医科大学校基金，基于DNA甲基化谱识别胃癌的分子亚型及其分子标记，2020/01-2021/12, 主持.
